BusinessChromaDex Adds New AnthOrigin™ to Its Proprietary Ingredient PortfolioBy Nasdaq OMXOct 3, 2016, 10:30 AM UTC
BusinessEmblemHealth and LaborPress Honor Heroic Actions of Union MembersBy Nasdaq OMXSep 30, 2016, 1:30 PM UTC
BusinessKaryopharm Publishes Preclinical Data in Nature Demonstrating Selinexor’s Potential in KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC)By Nasdaq OMXSep 29, 2016, 11:30 AM UTC
BusinessMyriad Appoints Chip Parkinson as EVP for Reimbursement StrategyBy Nasdaq OMXSep 29, 2016, 11:05 AM UTC
BusinessChembio Awarded CDC Contract for Zika, Dengue, and Chikungunya Surveillance Testing in India, Peru, Guatemala and HaitiBy Nasdaq OMXSep 28, 2016, 12:50 PM UTC
BusinessKaryopharm Publishes Preclinical and Phase 1 Clinical Data for Selinexor in Ovarian Cancer in Clinical Cancer Research PublicationBy Nasdaq OMXSep 28, 2016, 11:30 AM UTC
BusinessBioSig Technologies to Present at the Fifth Annual OktoberINVESTfest, US – Bavaria, Germany Investors Conference In New YorkBy Nasdaq OMXSep 27, 2016, 12:00 PM UTC
BusinessPreliminary clinical results for Entia Biosciences, Inc.’s new, proprietary ErgoD2® medical food show an average increase in kidney filtration rate of approximately 10% for over 75% of test subjects, after only three monthsBy Nasdaq OMXSep 26, 2016, 12:30 PM UTC
